Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 2 1Phase 1 1

Status

Recruiting 2Active not recruiting 1

Sponsor Class

OTHER 3NIH 2

Study Type

Interventional 3

Sponsor

Cancer Type

Head & Neck 3Endocrine 1

Conditions

Thyroid Neoplasms 2Differentiated Thyroid Carcinoma 1

Interventions

Magnetic Resonance Spectroscopy 284Specimen Handling 278pembrolizumab 255Cyclophosphamide 234Radiotherapy 224Nivolumab 182Cisplatin 172Biopsy 163Carboplatin 152Radiosurgery 139fludarabine 128Blood Specimen Collection 128Surveys and Questionnaires 117Gemcitabine 117Paclitaxel 114Standard of Care 110venetoclax 109Dexamethasone 103Bevacizumab 96Radiation 92Rituximab 89Oxaliplatin 86Capecitabine 86Cytarabine 85Drug Therapy 83Ipilimumab 81Doxorubicin 81durvalumab 80atezolizumab 74fludarabine phosphate 73

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
OTHER × Iodine-124 × 90 days × Clear all
NCT01704586 2026-05-12

CLERAD-PROBE

University of Wuerzburg

Phase NA Active not recruiting
340 enrolled
EndocrineHead & Neck

Differentiated Thyroid Carcinoma

NCT06961084 2026-04-22

Comparison of I-124 PET/CT for the Diagnosis of Thyroid Cancer

University of California, San Francisco

Phase 2 Recruiting
62 enrolled
Head & Neck

Thyroid Neoplasms

NCT03647358 2026-04-14

Lesion Dosimetry With Iodine-124 in Metastatic Thyroid Carcinoma

Memorial Sloan Kettering Cancer Center

Phase 1 Recruiting
60 enrolled
Head & Neck

Thyroid Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡